Daiwa Securities Group Inc. Horizon Therapeutics Public LTD CO Transaction History

Daiwa Securities Group Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$98.98 - $115.74 $58,101 - $67,939	-587 Reduced 3.25%	17,476 $2.02 Million
Q2 2023 Jul 31, 2023	SELL	$96.34 - $112.38 $24,085 - $28,095	-250 Reduced 1.37%	18,063 $1.86 Million
Q1 2023 May 02, 2023	BUY	$107.32 - $113.5 $47,757 - $50,507	445 Added 2.49%	18,313 $2 Million
Q4 2022 Feb 06, 2023	BUY	$62.39 - $113.8 $51,471 - $93,885	825 Added 4.84%	17,868 $2.03 Million
Q3 2022 Nov 02, 2022	BUY	$58.92 - $84.67 $11,371 - $16,341	193 Added 1.15%	17,043 $1.06 Million

Q2 2022 Aug 09, 2022	BUY	$79.4 - $116.36 $50,816 - $74,470	640 Added 3.95%	16,850 $1.34 Million
Q1 2022 Apr 29, 2022	BUY	$86.42 - $109.81 $57,987 - $73,682	671 Added 4.32%	16,210 $1.71 Million
Q4 2021 Feb 03, 2022	BUY	$98.56 - $119.91 $14,291 - $17,386	145 Added 0.94%	15,539 $1.67 Million
Q3 2021 Nov 05, 2021	BUY	$91.91 - $110.37 $24,539 - $29,468	267 Added 1.77%	15,394 $1.69 Million
Q2 2021 Aug 06, 2021	BUY	$86.24 - $95.92 $47,000 - $52,276	545 Added 3.74%	15,127 $1.42 Million
Q1 2021 May 03, 2021	BUY	$71.83 - $95.48 $382,135 - $507,953	5,320 Added 57.44%	14,582 $1.34 Million
Q4 2020 Feb 04, 2021	BUY	$67.0 - $84.39 $537,742 - $677,314	8,026 Added 649.35%	9,262 $678,000
Q3 2020 Nov 02, 2020	BUY	$55.23 - $79.93 $9,886 - $14,307	179 Added 16.93%	1,236 $96,000
Q4 2019 Jan 31, 2020	SELL	$25.43 - $36.67 $3,331 - $4,803	-131 Reduced 11.03%	1,057 $38,000
Q3 2019 Nov 04, 2019	BUY	$23.0 - $27.97 $575 - $699	25 Added 2.15%	1,188 $32,000
Q2 2019 Jul 24, 2019	BUY	$22.81 - $28.48 $26,528 - $33,122	1,163 New	1,163 $28,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.